Introduction
Glatiramer acetate [GA, poly(Y,E,A,K)n, Copolymer 1, Copaxone] is a synthetic random basic amino acid copolymer that is widely used for treatment of relapsing-remitting multiple sclerosis (MS). The efficacy of GA was first demonstrated in rodents developing experimental autoimmune encephalomyelitis (EAE), the animal model for MS and much of our knowledge about GA has been accumulated by use of this rodent model for MS (Arnon and Aharoni, 2004; Farina et al., 2005) . The mode of action of GA is complex and may include both competitive binding to MHC molecules on antigen-presenting cells (APC) (Arnon and Aharoni, 2004; Fridkis-Hareli et al., 1999; Fridkis-Hareli and Strominger, 1998; Fridkis-Hareli et al., 1994) and the induction of immunosuppressive cytokine-secreting copolymerspecific T-regulatory cells (Aharoni et al., 2000; Arnon and Aharoni, 2004; Duda et al., 2000; Farina et al., 2005; Stern et al., 2008) . Recent studies have suggested also the involvement of dendritic cells and type II monocytes in the process (Hussien et al., 2001; Kim et al., 2004; Vieira et al., 2003; Weber et al., 2007) .
Since binding to MHC molecules plays a role in the suppressive activity, additional copolymers with higher affinity for HLA-DR2, the MHC molecule strongly associated with MS, were synthesized (FridkisHareli et al., 2002) . Two of these novel copolymers, designated FYAK [poly(F,Y,A,K)n, CO-14, P1-2301] and VWAK [poly(V,W,A,K)n] were superior to GA in several aspects, including their affinity for HLA-DR2, their capacity to inhibit EAE and their induction of immunosuppressive cytokine-secreting T-regulatory cells (Fridkis-Hareli et al., 2002; Illes et al., 2004; Stern et al., 2004; Stern et al., 2008) . The immunosuppressive activity of GA, as well as that of FYAK, is not restricted to immunemediated central nervous system (CNS) conditions (Arnon and Aharoni, 2004; Stern et al., 2008) and we have previously reported that treatment with this copolymer also inhibits development of an ocular inflammatory disease, experimental autoimmune uveoretinitis (EAU) (Zhang et al., 2000) . EAU is induced in mice by immunization with a retinalspecific antigen, interphotoreceptor retinoid-binding protein (IRBP), and closely resembles EAE in various aspects (Caspi, 2002) .
In the present study, GA and FYAK, one of the two novel copolymers, have been compared in their capacity to inhibit induction of EAU, as well as several parameters related to the immunopathogenic process of this ocular disease. FYAK was more effective than GA in all tested parameters. Of particular interest is the observation that regulatory cell lines specific for FYAK produced immunosuppressive cytokines at levels higher than those made by GA-specific lines.
Materials and methods

Mice
Female B10.A (H-2 a ), B10.RIII (H-2 r ) and B10.BR (H-2 k ) mice, 6-8 weeks old, were obtained from Jackson Laboratory (Bar Harbor, ME). Animals were housed in a pathogen-free facility and all procedures involving animals were performed in compliance with the NIH Guidelines on Use of Animals in Research. Journal of Neuroimmunology 215 (2009) [43] [44] [45] [46] [47] [48] 
